KATHRYN MARINO: Open Payments
NPI 1457989352 · CAMDEN, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$266 in 8 payments from 8 companies in 2025. Trend: 2023 $72 · 2024 $136 · 2025 $266
Food & beverage: $196Education: $70
| Company | Payments | Amount |
|---|---|---|
| Stemline Therapeutics Inc. | 1 | $101 |
| Daiichi Sankyo Inc. | 1 | $70 |
| ARRAY BIOPHARMA INC | 1 | $19 |
| Gilead Sciences, Inc. | 1 | $16 |
| Legend Biotech USA Inc. | 1 | $16 |
| ABBVIE INC. | 1 | $15 |
| Genentech USA, Inc. | 1 | $14 |
| Lilly USA, LLC | 1 | $14 |
Products named: Orserdu, Enhertu, BRAFTOVI, Trodelvy, CARVYKTI, VENCLEXTA, Polivy, VERZENIO.
Industry payments across NJ — which companies pay providers there.
